Spi-1/PU.1 transgenic mice develop multistep erythroleukemias - PubMed (original) (raw)
Comparative Study
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias
F Moreau-Gachelin et al. Mol Cell Biol. 1996 May.
Abstract
Insertional mutagenesis of the spi-1 gene is associated with the emergence of malignant proerythroblasts during Friend virus-induced acute erythroleukemia. To determine the role of spi-1/PU.1 in the genesis of leukemia, we generated spi-1 transgenic mice. In one founder line the transgene was overexpressed as an unexpected-size transcript in various mouse tissues. Homozygous transgenic animals gave rise to live-born offspring, but 50% of the animals developed a multistep erythroleukemia within 1.5 to 6 months of birth whereas the remainder survived without evidence of disease. At the onset of the disease, mice became severely anemic. Their hematopoietic tissues were massively invaded with nontumorigenic proerythroblasts that express a high level of Spi-1 protein. These transgenic proerythroblasts are partially blocked in differentiation and strictly dependent on erythropoietin for their proliferation both in vivo and in vitro. A complete but transient regression of the disease was observed after erythrocyte transfusion, suggesting that the constitutive expression of spi-1 is related to the block of the differentiation of erythroid precursors. At relapse, erythropoietin-independent malignant proerythroblasts arose. Growth factor autonomy could be partially explained by the autocrine secretion of erythropoietin; however, other genetic events appear to be necessary to confer the full malignant phenotype. These results reveal that overexpression of spi-1 is essential for malignant erythropoiesis and does not alter other hematopoietic lineages.
Similar articles
- Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter-Fourt I, Morle F. Starck J, et al. Mol Cell Biol. 1999 Jan;19(1):121-35. doi: 10.1128/MCB.19.1.121. Mol Cell Biol. 1999. PMID: 9858537 Free PMC article. - Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts.
Scolan EL, Wendling F, Barnache S, Denis N, Tulliez M, Vainchenker W, Moreau-Gachelin F. Scolan EL, et al. Oncogene. 2001 Sep 6;20(39):5484-92. doi: 10.1038/sj.onc.1204708. Oncogene. 2001. PMID: 11571646 - Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.
Galson DL, Hensold JO, Bishop TR, Schalling M, D'Andrea AD, Jones C, Auron PE, Housman DE. Galson DL, et al. Mol Cell Biol. 1993 May;13(5):2929-41. doi: 10.1128/mcb.13.5.2929-2941.1993. Mol Cell Biol. 1993. PMID: 8474451 Free PMC article. - Erythroleukaemia induction by the Friend spleen focus-forming virus.
Ruscetti SK. Ruscetti SK. Baillieres Clin Haematol. 1995 Mar;8(1):225-47. doi: 10.1016/s0950-3536(05)80239-2. Baillieres Clin Haematol. 1995. PMID: 7663048 Review.
Cited by
- Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter-Fourt I, Morle F. Starck J, et al. Mol Cell Biol. 1999 Jan;19(1):121-35. doi: 10.1128/MCB.19.1.121. Mol Cell Biol. 1999. PMID: 9858537 Free PMC article. - The Effect of Bone Marrow Mesenchymal Stem Cells on the Granulocytic Differentiation of HL-60 Cells.
Nikkhah H, Safarzadeh E, Shamsasenjan K, Yousefi M, Lotfinejad P, Talebi M, Mohammadian M, Golafshan F, Movassaghpour A. Nikkhah H, et al. Turk J Haematol. 2018 Mar 1;35(1):42-48. doi: 10.4274/tjh.2016.0498. Epub 2017 Jun 13. Turk J Haematol. 2018. PMID: 28611013 Free PMC article. - Negative and translation termination-dependent positive control of FLI-1 protein synthesis by conserved overlapping 5' upstream open reading frames in Fli-1 mRNA.
Sarrazin S, Starck J, Gonnet C, Doubeikovski A, Melet F, Morle F. Sarrazin S, et al. Mol Cell Biol. 2000 May;20(9):2959-69. doi: 10.1128/MCB.20.9.2959-2969.2000. Mol Cell Biol. 2000. PMID: 10757781 Free PMC article. - Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.
Calero-Nieto FJ, Wood AD, Wilson NK, Kinston S, Landry JR, Göttgens B. Calero-Nieto FJ, et al. Nucleic Acids Res. 2010 Oct;38(19):6363-74. doi: 10.1093/nar/gkq490. Epub 2010 Jun 4. Nucleic Acids Res. 2010. PMID: 20525788 Free PMC article. - FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
Pawlikowska P, Delestré L, Gregoricchio S, Oppezzo A, Esposito M, Diop MB, Rosselli F, Guillouf C. Pawlikowska P, et al. Oncogene. 2023 Sep;42(37):2764-2775. doi: 10.1038/s41388-023-02800-9. Epub 2023 Aug 12. Oncogene. 2023. PMID: 37573408 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1981 Mar;78(3):1401-5 - PubMed
- Mol Cell Biol. 1993 Sep;13(9):5670-8 - PubMed
- Proc Natl Acad Sci U S A. 1981 Jun;78(6):3614-8 - PubMed
- Proc Natl Acad Sci U S A. 1983 Oct;80(20):6269-73 - PubMed
- Nucleic Acids Res. 1985 Mar 11;13(5):1431-42 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases